applied biosystems one various brands life technologies brand thermo fisher scientific corporation brand focused integrated systems genetic analysis include computerized machines consumables used within reagents merger applied biosystems invitrogen finalized creating life technologies latter acquired thermo fisher scientific prior applied biosystems brand owned various entities corporate group parented perkinelmer roots applied biosystems trace back geneco genetic systems company pioneer biotechnology company founded foster city early applied biosystems inc operated independently manufactured biochemicals automated genetic engineering diagnostic research instruments including principal brand dna sequencing machine used human genome project consortium centers applied biosystems close ties consortium project led idea founding celera genomics one several independent competitors applied biosystems inc delisted nasdaq acquired old company known perkinelmer pe applied biosystems division parent became consolidated acquisitions primary pe biosystems parent company reorganized changed name pe pe biosystems group formerly became publicly traded tracking stock parent along sister tracking stock company celera genomics parent became applera corporation applied biosystems name also returned year name change tracking stock pe biosystems group applera corporationapplied biosystems group sp company remains publicly traded operating group within applera corp along sibling operating group applera corporationcelera group applera derives name combination two component groups names november merger applied biosystems finalized creating global leader biotechnology reagents systems new company called life technologies company founded two scientistengineers hewlett packard sam eletr andr√© marion based technology developed leroy hood marvin h applied biosystems released first commercial instrument model protein sequencer machine enabled scientists determine order amino acids within purified protein turn correlated proteins function employees company reported firsttime revenue company led president chairman board sam eletr chief operating officer andre marion company doubled number employees stock went public nasdaq exchange symbol abio revenues million new product fluorescent molecular tag immunodiagnostic company released second commercial instrument model dna synthesizer made oligonucleotides short dna strands polymerase chain reaction pcr dna sequencing gene identification two sequencer synthesizer products allowed molecular biologists clone genes building oligonucleotides desired proteins dna automated dna sequencing began california institute technology using fluorescent dyes rights technology granted applied cit dr leroy hood dr lloyd smith together pioneered first dna sequencing applied biosystems sales revenue tripled million second yearly profit employees services included synthesizing custom dna protein fragments sequencing protein samples submitted customers third major instrument made applied model peptide synthesizer applied biosystems sales revenue grew nearly million third yearly profit two new products included model dna synthesizer dna synthesizer year company went international first time established wholly owned subsidiary great britain save shipping costs chemical sales overall accounted also applied biosystems acquired brownlee labs manufacturer columns pumps highperformance liquid chromatography hplc systems founder robert brownlee diagnosed aidsrelated complex brownlees technology brought new online pth amino acid however brownlee began new company viewed applied competitor applied brownlee settled lawsuit late brownlee publicly discussed contributions rocky relationship applied died early next andre marion became president chief executive officer sales revenue increased nearly million company introduced six new products totalling eleven automated instruments release model dna sequencing system using fluorescent tags revolutionized gene discovery model nucleic acid extractor became used medical labs isolate dna bacteria blood sam eletr resigned health reasons revenues increase nearly million employees another six new instruments applied biosystems acquired kratos division spectros international product line increased different automated instruments liquid chromatography columns components chemicals biochemicals consumables sales revenue grew million almost employees eight countries year first time genetic science reached milestone able identify individuals sales revenue reached nearly million applied biosystems maintained offices different countries introduced four new products company developed enzymebased reagent kits made promega corporation new field bioinformatics licensed trw inc also joint marketing began perkinelmer corporation cetus corporation formerly instruments reagents dna replication fastest growing segment instrument sales underwent cyclical slowdown economy entered recession first year applied revenues grow came less million employees new company developments included new instrumentation robotics detection dna fragments using companys fluorescent also us government approved financing support human genome project dr james watson founded consortium forecast project could completed years starting date cost cost next couple years japan began project sequence rice genome laboratories initiated programs sequence mouse fruit fly yeast applied sales revenue grew slightly almost million consumables service contracts account total sales dna sequencer dna synthesis instruments record sales fortyfive new consumable products six new instruments sales revenue grew million europe representing revenue asia pacific rim accounting company formed new subsidiary lynx therapeutics inc focus antisense dna research area therapeutics chronic myelogenous leukemia melanoma colorectal cancer february applied biosystems acquired became applied biosystems division part life sciences markets segment company andre marion applied biosystemss chairman president ceo became senior vice president perkinelmer president applied biosystems division year company worlds leading manufacturer instruments reagents polymerase chain reaction pcr marketed pcr reagents kits alliance hoffmanla roche perkinelmer reported net revenues billion life sciences accounted business company brandnew highly competitive genomics industry formed development new pharmaceuticals based work human genome project companies sequana therapeutics san diego human genome sciences maryland myriad genetics utah incyte pharmaceuticals later incyte genomics california millennium pharmaceuticals relied applied biosystems division made thermal cyclers automated sequencers new genomics upon andre marion retirement mike hunkapiller became president pe applied biosystems division sold thermal cycler meet human genome project goals perkinelmer developed mapping kits markers every million bases along chromosome also year dna fingerprinting using pcr became accepted court reliable forensic perkinelmer acquired tropix inc chemiluminescence company life sciences september tony l white baxter international inc became president chief executive officer company reorganized two separate operating divisions analytical instruments pe applied biosystems pe applied biosystems division accounted half perkinelmers total revenue net revenues revenues reached almost billion pe applied biosystems company acquired genscope inc linkage genetics inc linkage genetics unit combined zoogen form pe aggen focused genetic analysis services plant animal breeding pe applied biosystems division partnered hyseq inc work new dna chip technology also worked tecan us inc combinatorial chemistry automation systems also molecular informatics inc genetic data management analysis automated pe applied biosystems became pe biosystems divisions revenues reached million january perkinelmer acquired perseptive biosystems formerly framingham leader bioinstrumentation field made biomolecule purification systems protein noubar afeyan phd founder chairman ceo perseptive perkinelmer successor company set later tracking stock celera perkinelmer formed pe biosystems division consolidating applied biosystems perseptive biosystems tropix pe informatics formed perkinelmer combination two acquisitions molecular informatics nelson analytical systems existing units perkinelmer planning next new generation machines pe biosystems president michael w hunkapiller calculated would possible private industry decode human genome academic consortium could complete using resources single industrialscale center even though would require starting bold prediction given consortium target date set dr watson back forward year seven years away consortium already half way completion target date also meant dr hunkapillers idea would require competing customers applied biosystems sold sequencing machines chemical reagents however calculated would also mean doubling market hunkapiller brought dr j craig venter direct project tony white president perkinelmer corporation backed hunkapiller venture organized new company accomplish task may celera genomics formed rapidly accelerate human dna sequencing dr venter boldly declared media would complete genome decoding bold announcement prompted academic consortium accelerate deadline couple years also pe biosystems partnered hitachi ltd develop electrophoresisbased genetic analysis systems resulted chief new genomics instrument abi prism dna analyzer advanced human genome sequencing project nearly five years ahead schedule partnerships sold hundreds analyzers celera also others new machine cost major leap beyond predecessor fully automated allowing genetic decoding run around clock little supervision according venter machine revolutionary could decode single day amount genetic material dna labs could produce public consortium also bought one pe biosystems sequencers plans buy machine proved fast late march consortium announced revised timeline would release spring first draft sequence human year end pe biosystems groups sales reached focus new genomics perkinelmer corporation renamed pe sold old analytical instruments division egg inc also acquired perkinelmer name pe biosystems remained pe corp became pe biosystems group employees net revenues new instruments developed sold forensic human identification protein identification characterization metabolite pathway identification lead compound identification combinatorial april shareholders perkinelmer corporation approved reorganization perkinelmer pe corporation pureplay life science share perkinelmer stock pkn exchanged one share share respectively two new common share tracking stocks two component life sciences groups pe biosystems group celera genomics april two replacement tracking stocks new pe corporation issued dr michael w hunkapiller remained senior vice president pe corporation president pe may recapitalization company resulted issuance two new classes common stock called pe corporationpe biosystems group common stock pe corporationcelera genomics group common date trading began new stocks new york stock exchange great june board pe corporation announced twoforone split pe biosystems group common june genomics segment technology bubble peaking celera genomics cra pe biosystems peb among five genetics pioneers leading time along incyte genomics human genome sciences millennium pharmaceuticals five stocks exceeded price per share market ultimately crashing back november pe corporation changed name applera combining two partial names applied celera one pe biosystems group renamed applied biosystems group changed ticker symbol peb abi net revenues rose almost celera year made milestone headlines announced completed sequencing first assembly two largest genomes history fruit fly applied biosystems division applera reached revenues developed new workstation instrument specifically new field proteomics become celeras new core business focus shifted away gene discovery instrument analyzed protein samples per april celera genomics group announced decision shift role marketing data genetic database sister company applied biosystems group celera would instead develop pharmaceutical drugs applied biosystems better fit database applied already huge sales force place marketing instruments plans expand sales database electronic commerce applied biosystems reached revenues billion year took control celera support celera discovery system cds data tool answer specific genomic proteomic queries involving new genetic data field tens thousands singlenucleotide polymorphisms snps within human genome company developed another new tool combined first ever union triple quadrupole ion trap technologies proteomics database would remain celera shareholder approval complications celera would retain responsibility maintenance support existing customers would receive royalties applied catherine burzik joined applieds management orthoclinical applied developed new tool measured antibodyantigen binding realtime kinetic analysis binding interactions mike hunkapiller retired cathy burzik replaced president applied applera collaborated general electric abbott laboratories seattle genetics merck diagnostics development applied biosystmes also teamed northrop grumman cepheid sunnyvale california detect bacillus anthracis anthrax contamination case us postal company released new tools small molecule quantitation pharmaceutical drug development mexico applied biosystems collaborated national institute genomic medicine mexico instituto nacional de medicina genomica inmegen established applied biosystems sequencing genotyping unit applied biosystems acquired research products division ambion supplier rnabased reagents year influenza subtype avian flu strain scare company launched global initiative identify track infectious applied biosystems also acquired agencourt personal located beverly commercialize agencourts solid sequencing system abi solid sequencing nextgen dna sequencing platform announced mark stevenson appointed president chief operating officer applied november applied biosystems merged invitrogen forming life acquired thermo fisher scientific httpsenwikipediaorgwikiappliedbiosystems